Long-term effects of captopril in hypertension
- 31 August 1980
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 28 (3) , 316-323
- https://doi.org/10.1038/clpt.1980.168
Abstract
Captopril was given for treatment of hypertension alone or in combination with diuretics to 32 patients for 1-4 mo. periods. The decrement of mean blood pressure after 1 and 2 mo. correlated with pretreatment plasma renin activity (PRA) and the response of blood pressure to infusion of an angiotensin II antagonist. These correlations were no longer apparent after 4 mo. of treatment. When subjects with a decrement of mean blood pressure that exceeded 13 mm Hg were compared with nonresponders, responders not only had higher control PRA and higher PRA at 1 mo. of treatment, but had decreased plasma aldosterone levels, decreased urinary aldosterone excretion and increased serum K levels that persisted over the 4 mo. of observation. The reduction of plasma aldosterone correlated with the fall of mean blood pressure. Urinary kallikrein, catecholamines, electrolytes and endogenous creatinine clearance did not change in response to treatment. The antihypertensive activity of captopril on longt term administration probably depends in part on the blockade of angiotensin II, but other mechanisms cannot be excluded.Keywords
This publication has 11 references indexed in Scilit:
- EFFECT OF CAPTOPRIL (SQ-14225) ON BLOOD-PRESSURE, PLASMA-RENIN ACTIVITY AND ANGIOTENSIN-I CONVERTING ENZYME-ACTIVITY1979
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Haemodynamics of Orally-Active Converting Enzyme Inhibitor (SQ 14225) in Hypertensive PatientsClinical Science, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Sodium depletion and blood pressure response to 1‐sarcosine, 8‐isoleucine angiotensin II in hypertensionClinical Pharmacology & Therapeutics, 1978
- The Effect of the Converting Enzyme Inhibitor SQ 20.881 on Kinins, Renin‐Angiotensin‐Aldosterone and Catecholamines in Relation to Blood Pressure in Hypertensive PatientsActa Medica Scandinavica, 1978
- New Fluorogenic Substrates for α-Thrombin, Factor Xa, Kallikreins, and Urokinase1The Journal of Biochemistry, 1977
- A Non-Chromatographic Non-Extraction Radioimmunoassay for Serum AldosteroneJournal of Clinical Endocrinology & Metabolism, 1977
- Effects of two angiotensin II analogues on blood pressure in normal subjects with various sodium balancesLife Sciences, 1977